Last week, executive management of BioLargo’s subsidiary Clyra Medical Technologies met for the first time with the company’s newly formed Medical Advisory Board to discuss clinical trials, refine the company’s strategy for commercialization, and plan for development of additional products. This meeting comes in the wake of Clyra’s recently announced FDA 510(k) approval for its first advanced wound care product, a wound irrigation product based on the company’s proprietary antimicrobial chemistry.
The Medical Advisory Board meeting took place at the Fall 2019 Symposium for Advanced Wound Care (SAWC) in Las Vegas, a leading forum for the advancement of wound care practices and technology now in its 33rd year. The event was attended by thousands of physicians, researchers, scientists, podiatrists, wound care technology experts, and more.
Clyra’s Medical Advisory Board is comprised of over 30 experts, including medical doctors, surgeons, podiatrists, wound care researchers, and medical industry experts. Members of Clyra’s Medical Advisory Board offer Clyra unprecedented insight into the science and business of clinical wound care and provide invaluable counsel to Clyra as it prepares its first product for clinical trials and commercialization following its recent FDA approval.
To see Clyra’s Medical Advisory Board and learn about its members, visit https://www.clyramedical.com/advisoryboard
Clyra's President Steve Harrison comments on the Medical Advisory Board meeting, “We are pleased that we have been able to attract some of the best and brightest minds in diverse fields relevant to our powerful and innovative wound care products. Our Advisory Board includes world-renowned experts in wound care, infection research, orthopedic surgery, podiatry, medical product development, reimbursement and more. We look forward to a long and productive relationship with these world-class advisors, and we know our Advisory Board will play a big role in the successful commercial rollout of our advanced wound care products. Our first meeting at SAWC was a huge step toward achieving that goal”.
About Clyra Medical Technologies, Inc.